Atypical 5′ splice sites cause CFTR exon 9 to be vulnerable to skipping

American Journal of Human Genetics

Volumn 71, Issue 2, 2002, Pages 294-303

  Hefferon, Timothy W ^a   Broackes Carter, Fiona C ^b   Harris, Ann ^b   Cutting, Garry R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN;

ALLELE; ALTERNATIVE RNA SPLICING; ARTICLE; DNA FLANKING REGION; EXON; GENE INSERTION; GENE LOCUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; GENETICS; MOUSE; MUTATION; RNA SPLICING; SHEEP;

INSERTION SEQUENCES; OVIS ARIES;

ALTERNATIVE SPLICING; ANIMALS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXONS; HUMANS; MICE; MUTATION; RNA SPLICE SITES; SHEEP;

EID: 0035983216     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/341664     Document Type: Article

References (35)

1. Exon recognition in vertebrate splicing
2. Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology
3. Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D
4. Characterization and functional implications of the RNA binding properties of nuclear factor tdp-43, a novel splicing regulator of CFTR exon 9
5. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
6. Donor site competition is involved in the regulation of alternative splicing of the rat β-tropomyosin pre-mRNA
7. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
8. Extensive post-translational deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis
9. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
10. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium
11. Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human
12. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes: The polymorphic (TG)m locus explains the partial penetrance of the 5T polymorphism as a disease mutation
13. Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels
14. Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA
15. Alternative splicing: Increasing diversity in the proteomic world
16. U1 snRNP targets an essential splicing factor, U2AF65, to the 3′ splice site by a network of interactions spanning the exon
17. Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia
18. Reported in vivo splice-site mutations in the factor IX gene: Severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations
19. A mutation in the cystic fibrosis transmembrane conductance regulator gene produces different phenotypes depending on chromosomal background
20. Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens
21. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9
22. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations
23. Lung disease associated with the IVS8 5T allele of the CFTR gene
24. Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A→G splice-donorsite mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): How does G at position +3 result in aberrant splicing?
25. CFTR intron 9 [sic] poly-T tract length in men with congenital bilateral absence of the vas deferens
26. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element
27. Information analysis of human splice site mutations
28. RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression
29. Expression of an abundantly alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance
30. Molecular analysis of the ovine cystic fibrosis transmembrane conductance regulator gene
31. Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells
32. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A→G, 2751+2T→A, 296+1G→C, 1717-9T→CD565G) and one nonsense mutation (E822X) in the CFTR gene
33. Splice-site mutations in atherosclerosis candidate genes: Relating individual information to phenotype
34. Cooperation of 5′ and 3′ processing sites as well as intron and exon sequences in calcitonin exon recognition
35. CFTR gene variant for patients with congenital absence of vas deferens